0001127602-19-023018.txt : 20190628 0001127602-19-023018.hdr.sgml : 20190628 20190628161733 ACCESSION NUMBER: 0001127602-19-023018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190626 FILED AS OF DATE: 20190628 DATE AS OF CHANGE: 20190628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATUSKY CHRISTOPHER CENTRAL INDEX KEY: 0001231427 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 19929634 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-06-26 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231427 PATUSKY CHRISTOPHER C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 Restricted Stock Units 0 2019-06-26 4 A 0 2300 0 A 2020-06-26 2029-06-26 Common Stock 2300 2300 D Stock Options 76.36 2019-06-26 4 A 0 6310 0 A 2020-06-26 2029-06-26 Common Stock 6310 6310 D Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. Annual non-employee director grant of restricted stock units, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. /s/ John S. Hess, Jr. under Power of Attorney 2019-06-28